Mountain West Community Event: All About Minimal Residual Disease
Dr. Manni Mohyuddin, a Myeloma Specialist, joins the Mountain West Community to discuss what minimal residual disease is, how often//frequently it's tested, and what effects it can have on myeloma treatment decisions.
Audrey introduces the agenda of the event and our featured speaker Dr. Manni Mohyuddin.
Dr. Manni Mohyuddin shares about MRD testing.
Type your questions in the chat and we will answer them!
Audrey Burton-Bethke
Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.
Ghulam (Manni) Mohyuddin, MD
Dr. Mohyuddin completed his medical training at the prestigious Aga Khan University in Pakistan. He completed his internal medicine residency at the University of Kansas where he developed a passion for medical education and treating hematological malignancies. After residency, he pursued Chief Residency at the University of Kansas, focusing on mechanisms of novel educational delivery and improving access to research for trainees. He completed his fellowship at the University of Kansas, developing a clinical and research interest in multiple myeloma, drug repurposing, quality of scientific methods, end of life, cost-effective/evidence-based care and medical education. He enjoys the outdoors tremendously, and that drew him to life in Utah where he is currently an Assistant Professor at the Huntsman Cancer Institute with a focus on multiple myeloma.